Status:
SUSPENDED
Endoscopic Resection in Gastro-Esophageal Reflux Disease
Lead Sponsor:
Hospital St. Joseph, Marseille, France
Conditions:
GERD
Gastro Esophageal Reflux
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Currently patients with gastroesophageal reflux disease (GERD) are treated with proton pump inhibitors (PPIs). This long-term PPI treatment would likely increase the risk of pulmonary and digestive in...
Detailed Description
This is a monocentric prospective therapeutic study. Patients will be recruited in hepato-gastroenterology department of Saint Joseph Hospital (Marseille). A first clinical, endoscopic and PH impedanc...
Eligibility Criteria
Inclusion
- Patient with GERD resistant to medical treatment, or requiring daily long-term medical treatment
Exclusion
- Contraindications to the realization of a upper GI endoscopy
- Achalasia or other esophageal motor disorders
- Voluminous hiatal hernia Haemorrhagic, haemostasis or coagulation disorders
Key Trial Info
Start Date :
April 10 2017
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 10 2023
Estimated Enrollment :
15 Patients enrolled
Trial Details
Trial ID
NCT03357809
Start Date
April 10 2017
End Date
April 10 2023
Last Update
April 4 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
LAQUIERE
Marseille, France, 13008